middl
east
respiratori
syndrom
coronaviru
recent
emerg
pathogen
associ
sever
human
diseas
zoonot
spillov
camel
appear
play
major
role
transmiss
logist
difficulti
work
dromedari
contain
manag
anim
model
would
desir
report
shed
transmiss
viru
experiment
infect
alpaca
n
infect
contact
n
infecti
viru
detect
infect
anim
incontact
anim
alpaca
seroconvert
rechalleng
day
origin
infect
experiment
infect
anim
protect
reinfect
infect
contact
partial
protect
necropsi
specimen
immunolog
naiv
anim
n
obtain
day
postinfect
show
viru
upper
respiratori
tract
data
demonstr
effici
viru
replic
animaltoanim
transmiss
indic
alpaca
might
use
surrog
camel
laboratori
studi
cov
first
detect
sampl
man
saudi
arabia
sever
respiratori
diseas
sinc
identif
case
infect
document
casefat
rate
although
effici
humantohuman
transmiss
document
zoonot
spillov
probabl
play
major
role
human
infect
dromedari
camel
identifi
earli
recognit
viru
possibl
reservoir
host
diseas
although
patient
report
contact
camel
numer
investig
report
presenc
merscov
rna
infecti
viru
nasal
swab
specimen
dromedari
camel
saudi
arabia
qatar
oman
unit
arab
emir
nigeria
egypt
area
middl
east
africa
nearli
anim
test
serolog
posit
merscov
suggest
widespread
circul
among
camel
popul
histor
sampl
contain
specif
antibodi
merscov
long
ago
indic
merscov
circul
much
longer
origin
believ
young
anim
appear
greater
risk
product
infect
handl
practic
wean
ship
anim
might
play
major
role
animaltoanim
transmiss
mani
dromedari
camel
test
high
antibodi
titer
result
support
field
data
suggest
young
anim
becom
infect
immun
respons
probabl
repeatedli
boost
subsequ
exposur
viru
howev
current
unknown
whether
repeat
exposur
result
product
infect
whether
antibodi
gener
previou
infect
protect
previous
demonstr
dromedari
camel
experiment
infect
merscov
found
mild
upper
respiratori
tract
diseas
associ
shed
copiou
amount
viru
nasal
secret
develop
first
week
infect
howev
cost
dromedari
size
requir
special
facil
conduct
studi
would
use
identifi
altern
anim
model
respond
similarli
infect
merscov
report
character
alpaca
model
merscov
infect
evalu
viru
shed
patholog
transmiss
contact
protect
immun
week
initi
infect
result
indic
alpaca
might
use
substitut
dromedari
camel
certain
type
merscov
experi
anim
experi
approv
anim
care
use
committe
colorado
state
univers
everi
effort
made
minim
stress
pain
anim
anim
infect
lowpassag
human
isol
merscov
strain
strain
propag
vero
cell
cultur
dulbecco
modifi
eagl
medium
describ
nine
local
bred
alpaca
obtain
privat
sale
use
studi
anim
allow
acclim
facil
week
infect
fed
hay
ad
libitum
one
day
infect
anim
subcutan
inject
identif
temperaturesens
transpond
lifechip
destron
fear
dalla
fort
worth
airport
tx
usa
bodi
temperatur
monitor
throughout
studi
alpaca
hous
togeth
experiment
infect
intranas
instil
pfu
merscov
dilut
steril
phosphatebuff
salin
mlnare
two
day
later
alpaca
introduc
room
alpaca
hous
togeth
durat
studi
nasal
swab
specimen
collect
insert
rotat
steril
swab
nare
immedi
place
viru
transport
medium
frozen
assay
blood
collect
weekli
serumsepar
tube
detect
neutral
antibodi
anim
held
facil
day
postinfect
anim
reinfect
intranas
pfu
merscov
three
addit
alpaca
also
infect
serv
infect
control
evalu
tissu
distribut
viru
replic
nasal
swab
specimen
collect
daili
anim
day
time
anim
human
euthan
tissu
collect
necropsi
detect
infecti
viru
anim
includ
nasal
turbin
trachea
larynx
lung
lobe
sampl
plu
addit
sampl
includ
brain
kidney
liver
skelet
muscl
heart
spleen
bladder
mesenter
lymph
node
submandibular
lymph
node
mediastin
lymph
node
fix
formalin
histopatholog
immunohistochem
analysi
nasal
swab
specimen
serum
sampl
collect
alpaca
sampl
week
second
infect
anim
human
euthan
tissu
fix
neutralbuff
formalin
day
embed
paraffin
tissu
section
stain
hematoxylin
eosin
evalu
veterinari
pathologist
hbo
immunohistochem
analysi
preform
detect
merscov
antigen
use
rabbit
polyclon
antiserum
antigen
dilut
primari
antibodi
describ
merscov
titrat
nasal
swab
specimen
viru
transport
medium
homogen
tissu
plaqu
assay
describ
camel
volum
viru
transport
medium
consid
dilut
serial
dilut
prepar
medium
neutral
antibodi
detect
plaqu
reduct
neutral
test
prnt
describ
seroposit
anim
identifi
use
neutral
cutoff
field
studi
experiment
infect
suggest
mild
respiratori
diseas
associ
nasal
discharg
develop
merscovinfect
camel
similar
dromedari
none
alpaca
appreci
increas
bodi
temperatur
challeng
rechalleng
figur
unlik
dromedari
camel
none
alpaca
emerg
infecti
diseas
wwwcdcgoveid
vol
june
observ
nasal
discharg
cours
infect
alpaca
maintain
consist
activ
level
tempera
food
intak
throughout
studi
nasal
swab
specimen
collect
infect
anim
immedi
challeng
day
postinfect
day
postinfect
experiment
infect
anim
detect
infecti
viru
day
postinfect
stop
shed
viru
day
postinfect
figur
panel
b
cohous
anim
place
room
infect
anim
day
initi
viru
infect
nasal
swab
specimen
collect
cohous
anim
day
infect
anim
time
week
day
infecti
viru
detect
anim
day
anim
day
isol
infecti
viru
anim
figur
panel
although
infecti
viru
detect
anim
day
infecti
viru
detect
anim
day
figur
panel
specul
anim
becam
infect
contact
anim
anim
clear
infect
suggest
transmiss
link
intim
anim
contact
rather
aerosol
transmiss
test
whether
previou
infect
protect
subsequ
viru
challeng
origin
studi
anim
allow
clear
infect
rechalleng
intranas
infect
day
postinfect
challeng
also
perform
immunolog
alpaca
infect
control
immunolog
naiv
anim
becam
infect
shed
viru
day
postinfect
time
euthan
anim
becam
infect
contact
shed
minim
viru
day
rechalleng
day
contrast
anim
experiment
infect
complet
protect
rechalleng
shed
detect
quantiti
viru
figur
panel
c
serum
collect
weekli
test
neutral
antibodi
merscov
experiment
infect
anim
detect
level
antibodi
begin
day
tabl
although
infecti
viru
isol
cohous
anim
anim
neutral
antibodi
detect
first
day
anim
day
anim
tabl
nasal
turbin
upper
trachea
lower
trachea
larynx
lung
lobe
sampl
necropsi
alpaca
test
infecti
viru
use
plaqu
assay
viru
detect
nasal
turbin
larynx
trachea
alpaca
lung
lobe
test
figur
gross
lesion
observ
necropsi
alpaca
howev
microscop
analysi
formaldehydefix
tissu
section
anim
show
mild
squamou
metaplasia
epithelium
turbin
anim
figur
panel
rare
foci
mucos
eros
accompani
minimaltomild
subepitheli
infiltr
neutrophil
macrophag
fewer
lymphocyt
figur
panel
c
anim
also
follicular
hypertrophi
hyperplasia
drain
lymph
node
suggest
immun
activ
immunohistochem
analysi
detect
rare
scatter
viru
antigenposit
cell
respiratori
epithelium
turbin
figur
panel
b
rare
cell
interpret
intraepitheli
leukocyt
viru
antigen
detect
tissu
examin
anim
histopatholog
evid
mild
enceph
perivascular
infiltr
lymphocyt
monocyt
mild
gliosi
figur
panel
assay
brain
tissu
viru
either
isol
pcr
high
potenti
contamin
nasal
caviti
extract
brain
tissu
neg
viru
immunohistochem
analysi
etiolog
enceph
observ
remain
unknown
might
unrel
merscov
infect
mani
difficulti
associ
high
contain
experi
involv
dromedari
camel
thu
addit
anim
model
necessari
merscov
research
greater
avail
unit
state
smaller
size
test
alpaca
model
report
alpaca
model
merscov
infect
camelid
analysi
animaltoanim
transmiss
reinfect
dynam
infect
alpaca
shed
consider
quantiti
infecti
viru
nasal
although
lower
concentr
report
dromedari
camel
addit
none
infect
alpaca
notic
nasal
discharg
distinctli
differ
observ
camel
might
explain
rel
low
effici
contact
transmiss
observ
alpaca
antibodi
titer
alpaca
experiment
infect
alpaca
cohous
infect
alpaca
titer
determin
use
cutoff
infecti
viru
detect
nasal
swab
specimen
alpaca
cohous
experiment
infect
anim
cohous
anim
neutral
antibodi
merscov
indic
viru
transmiss
antibodi
titer
observ
approxim
seen
infect
dromedari
except
whose
antibodi
titer
remain
low
rechalleng
final
experiment
infect
alpaca
complet
protect
subsequ
viru
rechalleng
contactinfect
alpaca
partial
protect
result
suggest
infect
easili
spread
among
close
group
camelid
infect
merscov
camel
frequent
move
within
middl
east
graze
camel
show
race
movement
enabl
mix
close
mingl
anim
could
play
major
role
merscov
transmiss
among
anim
handler
khalafalla
et
al
report
anim
bound
slaughter
held
livestock
market
sever
day
transfer
abattoir
kept
hour
slaughter
data
suggest
handl
practic
could
promot
animaltoanim
viru
transmiss
time
slaughter
viru
could
potenti
transmit
slaughterhous
worker
major
question
relat
pathogenesi
merscov
infect
camel
great
relev
vaccin
strategi
whether
anim
infect
resist
reinfect
viru
shed
long
experiment
infect
anim
complet
protect
rechalleng
day
later
suggest
steril
immun
achiev
howev
anim
infect
contact
anim
shed
infecti
viru
reinfect
albeit
much
lower
level
infect
control
anim
anim
although
test
present
studi
might
surmis
incontact
anim
would
acquir
steril
immun
second
booster
infect
result
support
field
data
suggest
young
anim
becom
infect
probabl
receiv
booster
infect
older
anim
acquir
immun
suscept
infect
viru
shed
find
also
highlight
possibl
widespread
vaccin
dromedari
camel
could
result
major
decreas
viru
transmiss
human
date
neutral
antibodi
merscov
detect
camelid
outsid
africa
middl
east
howev
viru
introduc
immunolog
naiv
camelid
popul
probabl
would
readili
transmit
among
anim
mani
new
world
camelid
valu
fiber
transmiss
might
devast
fiberrel
industri
thu
travelassoci
case
merscov
infect
continu
document
humantohuman
viru
transmiss
possibl
humantoanim
viru
transmiss
monitor
studi
sever
limit
experiment
group
anim
limit
abil
perform
statist
analys
addit
evalu
protect
immun
week
origin
infect
rel
short
period
fulli
recapitul
season
exposur
thu
studi
necessari
better
understand
durat
immun
camel
alpaca
note
ad
proof
crameri
et
al
also
report
experiment
infect
respons
rechalleng
alpaca
middl
east
respiratori
syndrom
coronaviru
issu
emerg
infecti
diseas
